An experimental drug called DH20931 shows promise against triple-negative breast cancer by overwhelming cancer cells with toxic lipids called ceramides.
← News
Pollution Wins Pollution Wins Planet
Candidate breast cancer drug overloads tumors with 'surge' of toxic lipids
Triple-Negative Breast Cancer Cancer type targeted
Triggers Ceramide Surge In Cancer Cells Drug mechanism
Preclinical Testing On Human-Derived Tumors Study stage